NCT03467373 · Interventional trial
A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL
Overall registry status Completed
Phase 1
Conditions B-Cell Lymphoma, Non-Hodgkin Lymphoma
Delaware Valley sites
- Fox Chase-Temple Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory